| Songjian Lu | University of Pittsburgh School of Medicine |
| Yong Jae Shin | Samsung Medical Center, Sungkyunkwan University School of Medicine, Samsung Advanced Institute for Health Science & Technology, Sungkyunkwan University |
| Harim Koo | Institute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine |
| Dongquan Chen | The University of Alabama at Birmingham |
| Dongquan Chen | The University of Alabama at Birmingham |
| Brian Vaillant | Dell Medical School, The University of Texas at Austin |
| Erik P Sulman | The University of Texas MD Anderson Cancer Center |
| Erik P Sulman | The University of Texas MD Anderson Cancer Center |
| Shi-Yuan Cheng | The Ken & Ruth Davee Department of Neurology & Northwestern Brain Tumor Institute, Center for Genetic Medicine, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine |
| Xinghua Lu | University of Pittsburgh School of Medicine |
| Do-Hyun Nam | Institute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine, Samsung Advanced Institute for Health Science & Technology, Sungkyunkwan University |
| Do-Hyun Nam | Institute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine, Samsung Advanced Institute for Health Science & Technology, Sungkyunkwan University |
| Krishna P Bhat | The University of Texas MD Anderson Cancer Center |